Mucormycosis--a possible trigger pathogen for encapsulating peritoneal sclerosis.
作者信息
Tan J, Manickam R, Pisharam J, Telisinghe P, Chong V H
出版信息
Perit Dial Int. 2012 Jul-Aug;32(4):479-81. doi: 10.3747/pdi.2011.00241.
Abstract
摘要
相似文献
1
Mucormycosis--a possible trigger pathogen for encapsulating peritoneal sclerosis.
Perit Dial Int. 2012 Jul-Aug;32(4):479-81. doi: 10.3747/pdi.2011.00241.
2
Cocoon-like fibroadhesive tuberculous peritonitis in a peritoneal dialysis patient.
Chin J Physiol. 2012 Oct 31;55(5):361-5. doi: 10.4077/CJP.2012.BAA060.
3
Case report: acute bowel obstruction with an isolated transition point in peritoneal dialysis patients; a presentation of encapsulating peritoneal sclerosis?
BMC Nephrol. 2016 Jan 5;17:1. doi: 10.1186/s12882-015-0214-2.
4
Encapsulating Peritoneal Sclerosis - Rare Cause Of Bowel Obstruction.
Pol Przegl Chir. 2015 Jul 1;87(7):371-4. doi: 10.1515/pjs-2015-0073.
5
Encapsulating peritoneal sclerosis.
World J Gastroenterol. 2018 Jul 28;24(28):3101-3111. doi: 10.3748/wjg.v24.i28.3101.
6
Posttransplant encapsulating peritoneal sclerosis localized to the terminal ileum.
Perit Dial Int. 2010 Jul-Aug;30(4):480-2. doi: 10.3747/pdi.2009.00232.
7
[Encapsulating peritonitis: a rare cause of intestinal occlusion in a patient subjected to peritoneal dialysis].
Minerva Chir. 1988 Nov 30;43(22):1973-5.
8
A Rare Reason of Ileus in Renal Transplant Patients With Peritoneal Dialysis History: Encapsulated Peritoneal Sclerosis.
Exp Clin Transplant. 2015 Dec;13(6):588-92. doi: 10.6002/ect.2014.0036. Epub 2014 Oct 21.
9
Towards standardized reporting in studies of encapsulating peritoneal sclerosis.
Perit Dial Int. 2013 Sep-Oct;33(5):482-6. doi: 10.3747/pdi.2013.00165.
10
Encapsulated peritoneal sclerosis.
J Pak Med Assoc. 2022 Jan;72(1):192-193. doi: 10.47391/JPMA.22-007.
引用本文的文献
1
Gastrointestinal and Intra-Abdominal Mucormycosis in Non-Haematological Patients-A Comprehensive Review.
J Fungi (Basel). 2025 Apr 9;11(4):298. doi: 10.3390/jof11040298.
2
Encapsulating peritoneal sclerosis.
World J Gastroenterol. 2018 Jul 28;24(28):3101-3111. doi: 10.3748/wjg.v24.i28.3101.
本文引用的文献
1
Mucormycosis peritonitis: more than 2 years of disease-free follow-up after posaconazole salvage therapy after failure of liposomal amphotericin B.
Am J Kidney Dis. 2008 Feb;51(2):302-6. doi: 10.1053/j.ajkd.2007.09.026.
2
Rhinocerebral mucormycosis: the disease spectrum in 27 patients.
Mycoses. 2007 Jul;50(4):290-6. doi: 10.1111/j.1439-0507.2007.01364.x.
3
Tuberculous abdominal cocoon--a report of 6 cases and review of the Literature.
World J Emerg Surg. 2006 Jun 27;1:18. doi: 10.1186/1749-7922-1-18.
4
Encapsulating peritoneal sclerosis--a clinician's approach to diagnosis and medical treatment.
Perit Dial Int. 2005 Apr;25 Suppl 4:S30-8.
5
Epidemiology and outcome of zygomycosis: a review of 929 reported cases.
Clin Infect Dis. 2005 Sep 1;41(5):634-53. doi: 10.1086/432579. Epub 2005 Jul 29.
6
Novel perspectives on mucormycosis: pathophysiology, presentation, and management.
Clin Microbiol Rev. 2005 Jul;18(3):556-69. doi: 10.1128/CMR.18.3.556-569.2005.
7
Case report: abdominal cocoon associated with tuberculous pelvic inflammatory disease.
Br J Radiol. 2002 Feb;75(890):174-6. doi: 10.1259/bjr.75.890.750174.
8
9
Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry.
Am J Kidney Dis. 1991 Dec;18(6):660-7. doi: 10.1016/s0272-6386(12)80606-8.
Zotero 插件